Talo funds, researches and builds therapeutics companies, platforms and in-silico technologies.

Our flagship company is Automera, developing the next evolution in degradation platforms.


TLTX is a therapeutics development group focused on transforming the field of biotechnology using this middleware, bringing planet-scale coordination of economic and intellectual capital to modern drug development.

Learn more →